KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapiesOncotargetDate: (2017) Siglec 1 and 2 as potential biomarkers in autoimmune diseaseProteomics Clinical ApplicationsDate: (2016) Beneficial metabolic actions of a stable GIP agonist following pre-treatment with a SGLT2 inhibitor in high fat fed diabetic mice.Molecular and Cellular EndocrinologyDate: (2015) Current and future trends in biomarker discovery and development of companion diagnostics for arthritisExpert Review of Molecular DiagnosticsDate: (2014) Purification, characterization and molecular cloning of chymotrypsin inhibitor peptides from the venom of Burmese Daboia russelli siamensisPeptidesDate: (2013) Trypsin and chymotrypsin inhibitor peptides from the venom of Chinese Daboia russellii siamensisToxiconDate: (2013) Prevalence of KIR B haplotype in Irish rheumatoid arthritis patientsAnnals Rheumatic DiseaseDate: (2013) Diagnostic, Prognostic and Theranostic Genetic Biomarkers forRheumatoid ArthritisJournal of Clinical and Cellular ImmunologyDate: (2012) Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-α therapyRheumatology InternationalDate: (2012) Diagnostic, Prognostic and Theranostic Genetic Biomarkers for Rheumatoid ArthritisJournal of Clinical & Cellular ImmunologyDate: (2012)